Loading viewer...
investor_presentation
Format: PDF investor_presentation
Amyris is a synthetic biology company with a portfolio of platform molecules for clean beauty, functional ingredients, and health & wellness applications. The company demonstrated 140% sales growth from FY2018 to FY2019 and reported 56% gross margin, driven by consumer megatrends and proprietary science-enabled partnerships.
presentation
AkzoNobel 2022 Investor Update Grow Deliver
investor_presentation
76 Pages
AkzoNobel